RxVantage, a digital platform connecting health care providers to educational resources and experts from life science companies, has acquired onPoint Oncology, the leader in oncology reimbursement data and analytics. The partnership ensures that care teams will have access to onPoint's unique revenue cycle data and reimbursement insights as well as one-click access to educational resources and expertise from any life science company, all through the free RxVantage digital platform.
More than 6,000 medical practices across the US utilize RxVantage to connect and engage with over 50,000 experts from life science companies.
The acquisition of onPoint Oncology builds on RxVantage's rapidly expanding digital offerings for providers. In April, at the request of its customers, the company introduced RxVantage Virtual Meetings to help providers reestablish access to life science experts amidst the disruptions caused by COVID-19.
onPoint will operate as a wholly-owned subsidiary of RxVantage.
